Study to Evaluate Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Peripheral Neuropathic Pain
Clinical trial NCT00976534 · TERMINATED
Trial details
- NCT number
- NCT00976534
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.